Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MMP12 | P39900 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 7/20 | 0.42 |
| ▸ | CA1 | P00915 | 7/20 | 0.42 |
| ▸ | CA2 | P00918 | 7/20 | 0.42 |
| ▸ | CA9 | Q16790 | 7/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.41 |
| ▸ | CA4 | P22748 | 4/20 | 0.41 |
| ▸ | CA6 | P23280 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11391188 | 0.92 | LMNA (0.54) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL11391185 | 0.92 | LMNA (0.54) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL12837364 | 0.91 | LMNA (0.60) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL10618215 | 0.91 | LMNA (0.60) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL13466026 | 0.91 | LMNA (0.60) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL10618219 | 0.91 | LMNA (0.60) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL12837317 | 0.88 | LMNA (0.76) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL2007087 | 0.88 | LMNA (0.76) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL2007088 | 0.88 | LMNA (0.76) | LMNAKMT2ATSHRPOLBALDH1A1 | |
| SCHEMBL10617277 | 0.88 | LMNA (0.59) | LMNAKMT2ATSHRPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4157853-B1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC (CA) | 2024-07-31 | — | — | EP | disclosed |
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC. (CA) | 2023-08-10 | — | — | US | disclosed |
| EP-4157853-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | Giiant Pharma Inc. (CA) | 2023-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | PDE4A, PDE4B, PDE4C | LMNA 4364/4885KMT2A 3668/4885TSHR 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.